ONKURE THERAPEUTICS, INC. (OKUR) Current Ratio
- Current ratio · latest quarter: Value 26.75×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 26.75× | Current assets / current liabilities. $177.68M ÷ $6.64M ≈ 26.75× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 177.68M USD | Assets, Current |
| Current obligations | 6.64M USD | Liabilities, Current |
| Cash and equivalents | 166.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 9.88M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 2.00M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $177.68M | $6.64M | $166.50M | $9.88M | (m) | (m) | $2.00M | (m) | 26.75× |
| 2026-03-31 | $197.48M | $14.33M | $192.11M | (m) | (m) | (m) | $11.02M | (m) | 13.78× |
| 2025-12-31 | $60.84M | $5.92M | $59.05M | $0.00 | (m) | (m) | $1.43M | (m) | 10.28× |
| 2025-09-30 | $71.53M | $6.25M | $70.33M | (m) | (m) | (m) | $1.29M | (m) | 11.45× |
| 2025-06-30 | $84.55M | $7.60M | $83.37M | (m) | (m) | (m) | $2.38M | (m) | 11.13× |
| 2025-03-31 | $98.17M | $8.79M | $96.66M | (m) | (m) | (m) | $2.34M | (m) | 11.17× |
| 2024-12-31 | $113.00M | $10.53M | $110.76M | (m) | (m) | (m) | $2.97M | (m) | 10.73× |
| 2024-09-30 | $77.00M | $3.25M | $60.69M | (m) | (m) | (m) | $237.00K | (m) | 23.71× |
| 2024-06-30 | $77.99M | $1.35M | $35.97M | (m) | (m) | (m) | $64.00K | (m) | 57.86× |
| 2024-03-31 | $83.93M | $2.81M | $20.38M | (m) | (m) | (m) | $676.00K | (m) | 29.82× |
| 2023-12-31 | $33.77M | $7.29M | $29.88M | (m) | (m) | (m) | $3.42M | (m) | 4.64× |
| 2023-09-30 | $128.77M | $13.56M | $11.74M | (m) | (m) | (m) | $2.47M | (m) | 9.49× |
| 2023-06-30 | $146.32M | $13.74M | $9.08M | (m) | (m) | (m) | $1.83M | (m) | 10.65× |
| 2023-03-31 | $97.02M | $10.48M | $30.39M | (m) | (m) | (m) | $1.80M | (m) | 9.26× |
| 2022-12-31 | $106.35M | $7.12M | $19.93M | (m) | (m) | (m) | $1.89M | (m) | 14.93× |
| 2022-09-30 | $121.00M | $9.45M | $62.13M | (m) | (m) | (m) | $2.19M | (m) | 12.80× |
| 2022-06-30 | $132.01M | $8.34M | $118.26M | (m) | (m) | (m) | $1.56M | (m) | 15.84× |
| 2022-03-31 | $142.72M | $7.91M | $121.09M | (m) | (m) | (m) | $1.57M | (m) | 18.04× |
| 2021-12-31 | $153.73M | $6.20M | $124.66M | (m) | (m) | (m) | $2.02M | (m) | 24.79× |
| 2021-09-30 | $162.66M | $6.35M | $126.41M | (m) | (m) | (m) | $1.27M | (m) | 25.60× |
| 2021-06-30 | $171.14M | $3.34M | $140.37M | (m) | (m) | (m) | $434.00K | (m) | 51.30× |
| 2021-03-31 | $93.56M | $3.93M | $91.22M | (m) | (m) | (m) | $556.00K | (m) | 23.81× |
| 2020-12-31 | $55.02M | $4.58M | $53.61M | (m) | (m) | (m) | $908.00K | (m) | 12.01× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |